Stonepine Capital Management as of Dec. 31, 2024
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 52 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adma Biologics (ADMA) | 17.2 | $21M | 1.2M | 17.15 | |
| Evolus (EOLS) | 11.3 | $14M | 1.3M | 11.04 | |
| Tela Bio (TELA) | 5.7 | $7.1M | 2.4M | 3.02 | |
| Galapagos Nv- Spon Adr (GLPG) | 4.4 | $5.5M | 200k | 27.50 | |
| Zevra Therapeutics Com New (ZVRA) | 4.0 | $5.0M | 598k | 8.34 | |
| Verastem Com New (VSTM) | 3.6 | $4.5M | 870k | 5.17 | |
| ACADIA Pharmaceuticals (ACAD) | 3.3 | $4.0M | 220k | 18.35 | |
| Optinose Com New | 3.2 | $3.9M | 589k | 6.68 | |
| Anika Therapeutics (ANIK) | 3.2 | $3.9M | 238k | 16.46 | |
| Indivior Ord (INDV) | 3.1 | $3.8M | 305k | 12.43 | |
| Establishment Labs Holdings Ord (ESTA) | 3.0 | $3.7M | 80k | 46.07 | |
| Inhibikase Therapeutics Com New (IKT) | 3.0 | $3.7M | 1.1M | 3.25 | |
| Urogen Pharma (URGN) | 2.8 | $3.5M | 324k | 10.65 | |
| Xoma Corp Com New (XOMA) | 2.7 | $3.3M | 126k | 26.28 | |
| Day One Biopharmaceuticals I (DAWN) | 2.4 | $3.0M | 235k | 12.67 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 2.3 | $2.9M | 649k | 4.43 | |
| Scpharmaceuticals (SCPH) | 2.0 | $2.4M | 684k | 3.54 | |
| Surrozen Com New (SRZN) | 1.6 | $2.0M | 137k | 14.35 | |
| Inovio Pharmaceuticals Com Shs (INO) | 1.6 | $1.9M | 1.1M | 1.83 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $1.9M | 332k | 5.75 | |
| Myomo Com New (MYO) | 1.4 | $1.8M | 274k | 6.44 | |
| Calcimedica Com New (CALC) | 1.3 | $1.7M | 469k | 3.54 | |
| Aclaris Therapeutics (ACRS) | 1.3 | $1.6M | 663k | 2.48 | |
| Profound Medical Corp Com New (PROF) | 1.2 | $1.5M | 200k | 7.51 | |
| Jazz Pharmaceuticals Plc Us Listed Shs Usd (JAZZ) | 1.0 | $1.2M | 10k | 123.15 | |
| Vir Biotechnology (VIR) | 1.0 | $1.2M | 164k | 7.34 | |
| Milestone Pharmaceuticals In Com New (MIST) | 1.0 | $1.2M | 500k | 2.36 | |
| Biosante Pharmaceuticals (ANIP) | 0.9 | $1.1M | 20k | 55.28 | |
| Heron Therapeutics (HRTX) | 0.9 | $1.1M | 700k | 1.53 | |
| Exagen (XGN) | 0.8 | $1.0M | 251k | 4.10 | |
| 2seventy Bio Common Stock | 0.7 | $882k | 300k | 2.94 | |
| Iteos Therapeutics | 0.7 | $845k | 110k | 7.68 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $809k | 536k | 1.51 | |
| Kezar Life Sciences (KZR) | 0.6 | $739k | 110k | 6.72 | |
| Aytu Biopharma (AYTU) | 0.6 | $693k | 408k | 1.70 | |
| Adicet Bio (ACET) | 0.5 | $673k | 700k | 0.96 | |
| Kiora Pharmaceuticals (KPRX) | 0.5 | $663k | 201k | 3.30 | |
| Xeris Pharmaceuticals (XERS) | 0.5 | $618k | 182k | 3.39 | |
| Aquestive Therapeutics (AQST) | 0.5 | $570k | 160k | 3.56 | |
| Aprea Therapeutics Com New (APRE) | 0.4 | $491k | 149k | 3.29 | |
| Acelyrin | 0.3 | $417k | 133k | 3.14 | |
| Coherus Biosciences (CHRS) | 0.3 | $345k | 250k | 1.38 | |
| Polypid (PYPD) | 0.3 | $315k | 104k | 3.04 | |
| Hillevax | 0.2 | $274k | 132k | 2.07 | |
| An2 Therapeutics (ANTX) | 0.2 | $272k | 197k | 1.38 | |
| Vanda Pharmaceuticals (VNDA) | 0.1 | $120k | 25k | 4.79 | |
| Elevation Oncology (ELEV) | 0.1 | $113k | 200k | 0.56 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.1 | $110k | 15k | 7.32 | |
| Alimera Sciences Inc Cvr | 0.1 | $107k | 2.4M | 0.04 | |
| Allarity Therapeutics (ALLR) | 0.1 | $79k | 67k | 1.17 | |
| Revance Therapeutics | 0.1 | $71k | 23k | 3.04 | |
| Amarin Corporation Plc - Spons Adr New | 0.0 | $55k | 114k | 0.48 |
